Kevin Judice is the founder of Dice Therapeutics. Latest round: IPO. Backed by Sanofi, Angel investors. Based in South San Francisco, California.
J. Kevin Judice, Ph.D., is the co-founder and CEO of DICE Therapeutics, a biotechnology company focused on small-molecule immunology platforms. He is a Genentech veteran and longtime biotech entrepreneur based on the West Coast, having also led DiCE Molecules, a Stanford spinout that collaborated with Sanofi. DICE Therapeutics was acquired by Eli Lilly in 2023 for approximately $2.4 billion.
Full founder directory · Investor directory · Company funding database · Fundraising library